Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021)

Sodium glucose co-transporter 2 (SGLT2) inhibitors are now an established class of medications for the treatment of type 2 diabetes (T2D), no longer reserved for use by specialists in diabetes. They are being used increasingly for their cardiac and renal benefits by primary care, cardiology and rena...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Med (Lond)
Autori principali: Dashora, Umesh, Gregory, Robert, Winocour, Peter, Dhatariya, Ketan, Rowles, Susannah, Macklin, Andrew, Rayman, Gerry, Nagi, Dinesh, Whitehead, Katie, Beba, Hannah, De, Parijat, Patel, Dipesh C
Natura: Artigo
Lingua:Inglês
Pubblicazione: Royal College of Physicians 2021
Soggetti:
Concise Guidance
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140708/
https://ncbi.nlm.nih.gov/pubmed/34001571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2021-0045
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi